Skip to main content

Journal of Neuro-Oncology

Ausgabe 1/2015

Inhalt (26 Artikel)

Topic Review

Atypical meningoma: current management dilemmas and prospective clinical trials

Michael D. Jenkinson, Damien C. Weber, Brian J. Haylock, Conor L. Mallucci, Rasheed Zakaria, Mohsen Javadpour

Topic Review

Mouse models of primary central nervous system lymphomas: tools for basing funding and therapeutic strategies

Rym Ben Abdelwahed Bagga, Sabrina Donnou, Jérémie Cosette, Catherine Sautès-Fridman, Mahjoub Aouni, Sylvain Fisson

Laboratory Investigation

Tight regulation between cell survival and programmed cell death in GBM stem-like cells by EGFR/GSK3b/PP2A signaling

Demirkan B. Gürsel, Matei A. Banu, Nicholas Berry, Roberta Marongiu, Jan-Karl Burkhardt, Keith Kobylarz, Michael G. Kaplitt, Shahin Rafii, John A. Boockvar

Laboratory Investigation

Expression of astrocyte elevated gene-1 (AEG-1) in human meningiomas and its roles in cell proliferation and survival

Kyung-Jae Park, Mi Ok Yu, Na-Hyun Song, Doo-Sik Kong, Dong-Hyuk Park, Yang-Seok Chae, Yong-Gu Chung, Shin-Hyuk Kang

Laboratory Investigation

EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition

Yong Zhang, Shao-Xiang Wang, Ji-Wei Ma, Hai-Ying Li, Jie-Cheng Ye, Si-Ming Xie, Bin Du, Xue-Yun Zhong

Laboratory Investigation

Epidermal growth factor-like module containing mucin-like hormone receptor 2 expression in gliomas

Michael E. Ivan, Michael Safaee, Taemin Oh, Aaron J. Clark, Matthew Z. Sun, Joseph Kim, Orin Bloch, Arman Jahangiri, Joanna J. Phillips, Manish K. Aghi, Andrew T. Parsa

Laboratory Investigation

miR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells

Rui Zhang, Hui Luo, Shuai Wang, Zhengxin Chen, Lingyang Hua, Hong-Wei Wang, Wanghao Chen, Yongsheng Yuan, Xiaobin Zhou, Daqian Li, Shuying Shen, Tao Jiang, Yongping You, Ning Liu, Huibo Wang

Laboratory Investigation

Romo1 is associated with ROS production and cellular growth in human gliomas

Mi Ok Yu, Na-Hyun Song, Kyung-Jae Park, Dong-Hyuk Park, Se-Hyuk Kim, Yang-Seok Chae, Yong-Gu Chung, Sung-Gil Chi, Shin-Hyuk Kang

Laboratory Investigation

Single agent efficacy of the VEGFR kinase inhibitor axitinib in preclinical models of glioblastoma

Lei Lu, Dipongkor Saha, Robert L. Martuza, Samuel D. Rabkin, Hiroaki Wakimoto

Laboratory Investigation

Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer

Liqin Shen, Lei Chen, Yongsheng Wang, Xiaochun Jiang, Hongping Xia, Zhixiang Zhuang

Laboratory Investigation

EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma

Nicole McKinney, Liangping Yuan, Hongying Zhang, Jingbo Liu, Yoon-Jae Cho, Elisabeth Rushing, Matthew Schniederjan, Tobey J. MacDonald

Laboratory Investigation

Wnt activation affects proliferation, invasiveness and radiosensitivity in medulloblastoma

Roberta Salaroli, Alice Ronchi, Francesca Romana Buttarelli, Filippo Cortesi, Valeria Marchese, Elena Della Bella, Cristiano Renna, Caterina Baldi, Felice Giangaspero, Giovanna Cenacchi

Clinical Study

Gamma Knife radiosurgery for meningiomas arising from the tentorium: a 22-year experience

Seong-Hyun Park, Hideyuki Kano, Ajay Niranjan, Edward Monaco III, John C. Flickinger, L. Dade Lunsford

Clinical Study

Familial gliomas: cases in two pairs of brothers

Joseph A. Osorio, Shawn L. Hervey-Jumper, Kyle M. Walsh, Jennifer L. Clarke, Nicholas A. Butowski, Michael D. Prados, Mitchel S. Berger

Clinical Study

Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging

Seunghyun Lee, Seung Hong Choi, Inseon Ryoo, Tae Jin Yoon, Tae Min Kim, Se-Hoon Lee, Chul-Kee Park, Ji-Hoon Kim, Chul-Ho Sohn, Sung-Hye Park, Il Han Kim

Clinical Study

Choroid plexus tumor epidemiology and outcomes: implications for surgical and radiotherapeutic management

Donald M. Cannon, Pranshu Mohindra, Vinai Gondi, Tim J. Kruser, Kevin R. Kozak

Clinical Study

Ipilimumab and whole brain radiation therapy for melanoma brain metastases

Naamit K. Gerber, Robert J. Young, Christopher A. Barker, Jedd D. Wolchok, Timothy A. Chan, Yoshiya Yamada, Leigh Friguglietti, Kathryn Beal

Clinical Study

Diabetes insipidus in pediatric germinomas of the suprasellar region: characteristic features and significance of the pituitary bright spot

John-Paul Kilday, Suzanne Laughlin, Stacey Urbach, Eric Bouffet, Ute Bartels

Clinical Study

A better surgical resectability of WHO grade II gliomas is independent of favorable molecular markers

Dominik Cordier, Catherine Gozé, Sabine Schädelin, Valérie Rigau, Luigi Mariani, Hugues Duffau

Clinical Study

Quantitative analysis of tumor volume reduction after three-dimensional conformal radiation therapy for intracranial meningiomas

Nam Kwon Lee, Chul Yong Kim, Won Sup Yoon, Yong Gu Chung, Nam Joon Lee

Clinical Study

Pediatric choroid plexus tumors: epidemiology, treatments, and outcome analysis on 202 children from the SEER database

Roy W. R. Dudley, Michelle R. Torok, Danielle Gallegos, Arthur K. Liu, Michael H. Handler, Todd C. Hankinson

Clinical Study

Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study

Roger J. Packer, Brian R. Rood, David C. Turner, Clinton F. Stewart, Michael Fisher, Christopher Smith, Tina Young-Pouissant, Stewart Goldman, Rishi Lulla, Anu Banerjee, Ian Pollack, Larry Kun, Arzu Onar-Thomas, Shengjie Wu, James M. Boyett, Maryam Fouladi

Letter to the Editor

Nocardia abscesses mimicking tumor progression in gliomatosis cerebri responding to temozolomide

Luca Bertero, Paola Cassoni, Roberta Rudà

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.